THE COMPANY

Located in Scotland, United Kingdom, Omega Diagnostics Group
PLC is an AIM-listed public company on the London Stock Exchange.
(Ticker Symbol: ODX). It was formed in September 2006 when Omega
Diagnostics Limited completed a “reverse acquisition” of an AIM-listed
cash shell company called Quintessentially English PLC.

In September 2007, the company completed the acquisition of two companies,
Genesis Diagnostics Limited and Cambridge Nutritional Sciences Limited.

In September 2009, the company acquired Co-Tek (South West) Ltd., a company
manufacturing bacterial disease diagnostic assays.

The Group now provides high quality IVD products for use in Hospitals,
Blood Banks, Clinics and Laboratories in over 100 countries and specialises in
the areas of Food Intolerance, Autoimmune Disease and Infectious Disease.

For more information on the company and its subsidiaries please click
on the links below.  Further details are contained within the Investor
Relations pages:

Omega Diagnostics Limited
stay on this website

Genesis Diagnostics Limited

Autoimmune Diagnostic/Food Intolerance Tests

Cambridge Nutritional Sciences Limited

Food Intolerance Tests and Testing Service

Andrew Shepherd
Founder and Chief Executive
contact: andrews@omegadiagnostics.co.uk